Mitchell S. Anscher

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Lung

Concepts & Ideas

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Moore Joseph A; Gordon John J; Anscher Mitchell S; Siebers Jeffrey V
Comparisons of treatment optimization directly incorporating random patient setup uncertainty with a margin-based approach.
Koontz Bridget F; Chino Junzo; Lee W Robert; Hahn Carol A; Buckley Niall; Huang Samuel; Kim Jay; Reagan Robert; Joyner Raymond; Anscher Mitchell S
Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer.
Scarantino Charles W; Prestidge Bradley R; Anscher Mitchel S; Ferree Carolyn R; Kearns William T; Black Robert D; Bolick Natasha G; Beyer Gloria P
The observed variance between predicted and measured radiation dose in breast and prostate patients utilizing an in vivo dosimeter.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Mitchell S. Anscher (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Moore Joseph A; Gordon John J; Anscher Mitchell S; Siebers Jeffrey V
Comparisons of treatment optimization directly incorporating random patient setup uncertainty with a margin-based approach.
Medical physics 2009;36(9):3880-90.
2009: Koontz Bridget F; Chino Junzo; Lee W Robert; Hahn Carol A; Buckley Niall; Huang Samuel; Kim Jay; Reagan Robert; Joyner Raymond; Anscher Mitchell S
Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer.
Brachytherapy 2009;8(2):191-6.
2008: Scarantino Charles W; Prestidge Bradley R; Anscher Mitchel S; Ferree Carolyn R; Kearns William T; Black Robert D; Bolick Natasha G; Beyer Gloria P
The observed variance between predicted and measured radiation dose in breast and prostate patients utilizing an in vivo dosimeter.
International journal of radiation oncology, biology, physics 2008;72(2):597-604.
2008: Anscher Mitchell S; Thrasher Bradley; Zgonjanin Larisa; Rabbani Zahid N; Corbley Michael J; Fu Kai; Sun Lihong; Lee Wen-Cherng; Ling Leona E; Vujaskovic Zeljko
Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury.
International journal of radiation oncology, biology, physics 2008;71(3):829-37.
2008: Koontz Bridget F; Mouraviev Vladimir; Johnson Jeffrey L; Mayes Janice; Chen Stephanie H; Wong Terence Z; Anscher Mitchell S; Sun Leon; Moul Judd; Polascik Thomas J
Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer.
International journal of radiation oncology, biology, physics 2008;71(2):358-61.
2008: Miles Edward F; Nelson John W; Alkaissi Ali K; Das Shiva; Clough Robert W; Anscher Mitchell S; Oleson James R
Equivalent uniform dose, D(90), and V(100) correlation with biochemical control after low-dose-rate prostate brachytherapy for clinically low-risk prostate cancer.
Brachytherapy 2008;7(2):206-11.
2008: Zhao Lujun; Sheldon Kerby; Chen Ming; Yin Moli S; Hayman James A; Kalemkerian Gregory P; Arenberg Doug; Lyons Susan E; Curtis Jeffrey L; Davis Mary; Cease Kemp B; Brenner Dean; Anscher Mitchell S; Lawrence Theodore S; Kong Feng Ming
The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2008;59(2):232-9.
2007: Rabbani Zahid N; Salahuddin Fawzia K; Yarmolenko Pavel; Batinic-Haberle Ines; Thrasher Bradley A; Gauter-Fleckenstein Benjamin; Dewhirst Mark W; Anscher Mitchell S; Vujaskovic Zeljko
Low molecular weight catalytic metalloporphyrin antioxidant AEOL 10150 protects lungs from fractionated radiation.
Free radical research 2007;41(11):1273-82.
2007: Beyer Gloria P; Scarantino Charles W; Prestidge Bradley R; Sadeghi Amir G; Anscher Mitchell S; Miften Moyed; Carrea Tammy B; Sims Marianne; Black Robert D
Technical evaluation of radiation dose delivered in prostate cancer patients as measured by an implantable MOSFET dosimeter.
International journal of radiation oncology, biology, physics 2007;69(3):925-35.
2007: Stephenson Andrew J; Scardino Peter T; Kattan Michael W; Pisansky Thomas M; Slawin Kevin M; Klein Eric A; Anscher Mitchell S; Michalski Jeff M; Sandler Howard M; Lin Daniel W; Forman Jeffrey D; Zelefsky Michael J; Kestin Larry L; Roehrborn Claus G; Catton Charles N; DeWeese Theodore L; Liauw Stanley L; Valicenti Richard K; Kuban Deborah A; Pollack Alan
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2035-41.
2007: Marguet Charles; Raj Ganesh V; Brashears James H; Anscher Mitchell S; Ludwig Kirk; Mouraviev Vladimir; Robertson Cary N; Polascik Thomas J
Rectourethral fistula after combination radiotherapy for prostate cancer.
Urology 2007;69(5):898-901.
2007: Fleckenstein Katharina; Gauter-Fleckenstein Benjamin; Jackson Isabel L; Rabbani Zahid; Anscher Mitchell; Vujaskovic Zeljko
Using biological markers to predict risk of radiation injury.
Seminars in radiation oncology 2007;17(2):89-98.
2007: Rabbani Zahid N; Batinic-Haberle Ines; Anscher Mitchell S; Huang Jie; Day Brian J; Alexander Elaine; Dewhirst Mark W; Vujaskovic Zeljko
Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury.
International journal of radiation oncology, biology, physics 2007;67(2):573-80.
2007: Moul Judd W; Sun Leon; Hotaling James M; Fitzsimons Nicholas J; Polascik Thomas J; Robertson Cary N; Dahm Philipp; Anscher Mitchell S; Mouraviev Vladimir; Pappas Paul A; Albala David M
Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening.
The Journal of urology 2007;177(2):499-503; discussion 503-4.
2006: Anscher Mitchell S; Garst Jennifer; Marks Lawrence B; Larrier Nicole; Dunphy Frank; Herndon James E; Clough Robert; Marino Christine; Vujaskovic Zeljko; Zhou Sumin; Dewhirst Mark W; Shafman Timothy D; Crawford Jeffrey
Assessing the ability of the antiangiogenic and anticytokine agent thalidomide to modulate radiation-induced lung injury.
International journal of radiation oncology, biology, physics 2006;66(2):477-82.
2006: Evans Elizabeth S; Kocak Zafer; Zhou Su-Min; Kahn Daniel A; Huang Hong; Hollis Donna R; Light Kim L; Anscher Mitchell S; Marks Lawrence B
Does transforming growth factor-beta1 predict for radiation-induced pneumonitis in patients treated for lung cancer?
Cytokine 2006;35(3-4):186-92.
2006: Czito Brian G; Anscher Mitchell S; Willett Christopher G
Radiation therapy in the treatment of cholangiocarcinoma.
Oncology (Williston Park, N.Y.) 2006;20(8):873-84; discussion 886-8, 893-5.
2006: Anscher Mitchell S; Thrasher Bradley; Rabbani Zahid; Teicher Beverly; Vujaskovic Zeljko
Antitransforming growth factor-beta antibody 1D11 ameliorates normal tissue damage caused by high-dose radiation.
International journal of radiation oncology, biology, physics 2006;65(3):876-81.
2006: Anscher Mitchell S; Anscher Barbara M
Medical malpractice in the age of technology: how specialty societies can make a difference.
Brachytherapy 2006;5(2):131-4.
2006: Anscher M S; Clough R; Robertson C N; Prosnitz L R; Dahm P; Walther P; Donatucci C F; Albala D M; Febbo P; George D J; Sun L; Moul J W
Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate.
Prostate cancer and prostatic diseases 2006;9(3):254-60.
2006: Hu C K; McCall S; Madden J; Huang H; Clough R; Jirtle R L; Anscher M S
Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer.
Prostate cancer and prostatic diseases 2006;9(1):62-7.
2005: Kirkpatrick John P; Anscher Mitchell S
Radiotherapy for locally recurrent prostate cancer.
Clinical advances in hematology & oncology : H&O 2005;3(12):933-42.
2005: Anscher Mitchell S
The irreversibility of radiation-induced fibrosis: fact or folklore?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8551-2.
2005: Hart Justin P; Broadwater Gloria; Rabbani Zahid; Moeller Benjamin J; Clough Robert; Huang Dale; Sempowski Gregory A; Dewhirst Mark; Pizzo Salvatore V; Vujaskovic Zeljko; Anscher Mitchell S
Cytokine profiling for prediction of symptomatic radiation-induced lung injury.
International journal of radiation oncology, biology, physics 2005;63(5):1448-54.
2005: Moeller Benjamin J; Batinic-Haberle Ines; Spasojevic Ivan; Rabbani Zahid N; Anscher Mitchell S; Vujaskovic Zeljko; Dewhirst Mark W
A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness.
International journal of radiation oncology, biology, physics 2005;63(2):545-52.
2005: Black Robert D; Scarantino Charles W; Mann Gregory G; Anscher Mitchell S; Ornitz Robert D; Nelms Benjamin E
An analysis of an implantable dosimeter system for external beam therapy.
International journal of radiation oncology, biology, physics 2005;63(1):290-300.
2005: West Catharine M L; McKay Michael J; Hölscher Tobias; Baumann Michael; Stratford Ian J; Bristow Robert G; Iwakawa Mayumi; Imai Takashi; Zingde Surekha M; Anscher Mitchell S; Bourhis Jean; Begg Adrian C; Haustermans Karin; Bentzen Søren M; Hendry Jolyon H
Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meeting.
International journal of radiation oncology, biology, physics 2005;62(5):1264-73.
2005: Anscher Mitchell S
PSA kinetics and risk of death from prostate cancer: in search of the Holy Grail of surrogate end points.
JAMA : the journal of the American Medical Association 2005;294(4):493-4.
2005: Scarantino Charles W; Rini Christopher J; Aquino Migdalia; Carrea Tammy B; Ornitz Robert D; Anscher Mitchell S; Black Robert D
Initial clinical results of an in vivo dosimeter during external beam radiation therapy.
International journal of radiation oncology, biology, physics 2005;62(2):606-13.
2005: Anscher Mitchell S; Chen Liguang; Rabbani Zahid; Kang Song; Larrier Nicole; Huang Hong; Samulski Thaddeus V; Dewhirst Mark W; Brizel David M; Folz Rodney J; Vujaskovic Zeljko
Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy.
International journal of radiation oncology, biology, physics 2005;62(1):255-9.
2005: Anscher Mitchell S; Vujaskovic Zeljko
Mechanisms and potential targets for prevention and treatment of normal tissue injury after radiation therapy.
Seminars in oncology 2005;32(2 Suppl 3):S86-91.
2005: Anscher Mitchell S; Kong Feng-Ming
In regard to De Jaeger et al.: significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer (INT J RADIAT ONCOL BIOL PHYS 2004;58:1378-1387).
International journal of radiation oncology, biology, physics 2005;61(4):1276-7.
2005: Miller Keith L; Shafman Timothy D; Anscher Mitchell S; Zhou Su-Min; Clough Robert W; Garst Jennifer L; Crawford Jeffrey; Rosenman Julian; Socinski Mark A; Blackstock William; Sibley Gregory S; Marks Lawrence B
Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer?
International journal of radiation oncology, biology, physics 2005;61(1):64-9.
2005: Rabbani Zahid N; Anscher Mitchell S; Folz Rodney J; Archer Emerald; Huang Hong; Chen Liguang; Golson Maria L; Samulski Thaddeus S; Dewhirst Mark W; Vujaskovic Zeljko
Overexpression of extracellular superoxide dismutase reduces acute radiation induced lung toxicity.
BMC cancer 2005;5():59.
2005: Kasibhatla M; Peterson B; Anscher M S
What is the best postoperative treatment for patients with pT3bN0M0 adenocarcinoma of the prostate?
Prostate cancer and prostatic diseases 2005;8(2):167-73.
2004: Chen Liguang; Brizel David M; Rabbani Zahid N; Samulski Thaddeus V; Farrell Catherine L; Larrier Nicole; Anscher Mitchell S; Vujaskovic Zeljko
The protective effect of recombinant human keratinocyte growth factor on radiation-induced pulmonary toxicity in rats.
International journal of radiation oncology, biology, physics 2004;60(5):1520-9.
2004: Stone Helen B; Moulder John E; Coleman C Norman; Ang K Kian; Anscher Mitchell S; Barcellos-Hoff Mary Helen; Dynan William S; Fike John R; Grdina David J; Greenberger Joel S; Hauer-Jensen Martin; Hill Richard P; Kolesnick Richard N; Macvittie Thomas J; Marks Cheryl; McBride William H; Metting Noelle; Pellmar Terry; Purucker Mary; Robbins Mike E; Schiestl Robert H; Seed Thomas M; Tomaszewski Joseph E; Travis Elizabeth L; Wallner Paul E; Wolpert Mary; Zaharevitz Daniel
Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003.
Radiation research 2004;162(6):711-28.
2004: Quaranta Brian P; Marks Lawrence B; Anscher Mitchell S
Prostatectomy vs brachytherapy for localized prostate cancer.
Oncology (Williston Park, N.Y.) 2004;18(13):1582, 1585.
2004: Marks Lawrence B; Garst Jennifer; Socinski Mark A; Sibley Gregory; Blackstock A William; Herndon James E; Zhou Sunmin; Shafman Timothy; Tisch Andrea; Clough Robert; Yu Xiaoli; Turrisi Andrew; Anscher Mitchell; Crawford Jeffrey; Rosenman Julian;
Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(21):4329-40.
2004: Quaranta Brian P; Marks Lawrence B; Anscher Mitchell S
Comparing radical prostatectomy and brachytherapy for localized prostate cancer.
Oncology (Williston Park, N.Y.) 2004;18(10):1289-302; discussion 1302-4, 1309.
2004: Anscher Mitchell S
Salvage radiotherapy for recurrent prostate cancer: the earlier the better.
JAMA : the journal of the American Medical Association 2004;291(11):1380-2.
2004: Czito Brian G; Hong Timothy J; Cohen Darrel P; Tyler Douglas S; Lee Catherine G; Anscher Mitchell S; Ludwig Kirk A; Seigler Hilliard F; Mantyh Christopher; Morse Michael A; Lockhart Albert C; Petros William P; Honeycutt Wanda; Spector Neil L; Ertel Phillip J; Mangum Steve G; Hurwitz Herbert I
A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
International journal of radiation oncology, biology, physics 2004;58(3):779-85.
2003: Kang Song K; Rabbani Zahid N; Folz Rodney J; Golson Maria L; Huang Hong; Yu Daohai; Samulski Thaddeus S; Dewhirst Mark W; Anscher Mitchell S; Vujaskovic Zeljko
Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury.
International journal of radiation oncology, biology, physics 2003;57(4):1056-66.
2003: Rabbani Zahid N; Anscher Mitchell S; Zhang Xiuwu; Chen Liguang; Samulski Thaddeus V; Li Chuan-Yuan; Vujaskovic Zeljko
Soluble TGFbeta type II receptor gene therapy ameliorates acute radiation-induced pulmonary injury in rats.
International journal of radiation oncology, biology, physics 2003;57(2):563-72.
2003: Stone Helen B; Coleman C Norman; Anscher Mitchell S; McBride William H
Effects of radiation on normal tissue: consequences and mechanisms.
The lancet oncology 2003;4(9):529-36.
2003: Marks Lawrence B; Yu Xiaoli; Vujaskovic Zjelko; Small William; Folz Rodney; Anscher Mitchell S
Radiation-induced lung injury.
Seminars in radiation oncology 2003;13(3):333-45.
2003: Bentzen Soren M; Dörr Wolfgang; Anscher Mitchell S; Denham James W; Hauer-Jensen Martin; Marks Lawrence B; Williams Jacqueline
Normal tissue effects: reporting and analysis.
Seminars in radiation oncology 2003;13(3):189-202.
2003: Anscher Mitchell S; Marks Lawrence B; Shafman Timothy D; Clough Robert; Huang Hong; Tisch Andrea; Munley Michael; Herndon James E; Garst Jennifer; Crawford Jeffrey; Jirtle Randy L
Risk of long-term complications after TFG-beta1-guided very-high-dose thoracic radiotherapy.
International journal of radiation oncology, biology, physics 2003;56(4):988-95.
2003: Jamieson Timothy A; Brizel David M; Killian J Keith; Oka Yoshihiko; Jang Hong-Seok; Fu Xiaolong; Clough Robert W; Vollmer Robin T; Anscher Mitchell S; Jirtle Randy L
M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis.
BMC cancer 2003;3():4.
2003: Das Shiva; Cullip Timothy; Tracton Gregg; Chang Sha; Marks Lawrence; Anscher Mitchell; Rosenman Julian
Beam orientation selection for intensity-modulated radiation therapy based on target equivalent uniform dose maximization.
International journal of radiation oncology, biology, physics 2003;55(1):215-24.
2002: Vujaskovic Zeljko; Feng Qin Fu; Rabbani Zahid N; Samulski Thaddeus V; Anscher Mitchell S; Brizel David M
Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity.
Experimental lung research 2002;28(7):577-90.
2002: Vujaskovic Zeljko; Batinic-Haberle Ines; Rabbani Zahid N; Feng Qin-fu; Kang Song K; Spasojevic Ivan; Samulski Thaddeus V; Fridovich Irwin; Dewhirst Mark W; Anscher Mitchell S
A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury.
Free radical biology & medicine 2002;33(6):857-63.
2002: Vujaskovic Zeljko; Feng Qin-Fu; Rabbani Zahid N; Anscher Mitchell S; Samulski Thaddeus V; Brizel David M
Radioprotection of lungs by amifostine is associated with reduction in profibrogenic cytokine activity.
Radiation research 2002;157(6):656-60.
2002: Kang Song K; Chou Rachel H; Dodge Richard K; Clough Robert W; Kang Hi-Sung L; Hahn Carol A; Whitehurst Arthur W; Buckley Niall J; Kim Jay H; Joyner Raymond E; Montana Gustavo S; Ingram Sally S; Anscher Mitchell S
Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy.
International journal of radiation oncology, biology, physics 2002;53(1):99-103.
2002: Woel Roxanne T; Munley Michael T; Hollis Donna; Fan Ming; Bentel Gunilla; Anscher Mitchell S; Shafman Timothy; Coleman R Edward; Jaszczak Ronald J; Marks Lawrence B
The time course of radiation therapy-induced reductions in regional perfusion: a prospective study with >5 years of follow-up.
International journal of radiation oncology, biology, physics 2002;52(1):58-67.
2001: Onaitis M W; Noone R B; Fields R; Hurwitz H; Morse M; Jowell P; McGrath K; Lee C; Anscher M S; Clary B; Mantyh C; Pappas T N; Ludwig K; Seigler H F; Tyler D S
Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival.
Annals of surgical oncology 2001;8(10):801-6.
2001: White R R; Hurwitz H I; Morse M A; Lee C; Anscher M S; Paulson E K; Gottfried M R; Baillie J; Branch M S; Jowell P S; McGrath K M; Clary B M; Pappas T N; Tyler D S
Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas.
Annals of surgical oncology 2001;8(10):758-65.
2001: Hernando M L; Marks L B; Bentel G C; Zhou S M; Hollis D; Das S K; Fan M; Munley M T; Shafman T D; Anscher M S; Lind P A
Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer.
International journal of radiation oncology, biology, physics 2001;51(3):650-9.
2001: Fan M; Marks L B; Lind P; Hollis D; Woel R T; Bentel G G; Anscher M S; Shafman T D; Coleman R E; Jaszczak R J; Munley M T
Relating radiation-induced regional lung injury to changes in pulmonary function tests.
International journal of radiation oncology, biology, physics 2001;51(2):311-7.
2001: Anscher M S; Marks L B; Shafman T D; Clough R; Huang H; Tisch A; Munley M; Herndon J E; Garst J; Crawford J; Jirtle R L
Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(17):3758-65.
2001: Anscher M S
Re: The development of erectile dysfunction in men treated for prostate cancer.
The Journal of urology 2001;166(3):1010.
2001: Kang S K; Chou R H; Dodge R K; Clough R W; Kang H L; Bowen M G; Steffey B A; Das S K; Zhou S M; Whitehurst A W; Buckley N J; Kim J H; Joyner R E; Sarmina I; Montana G S; Ingram S S; Anscher M S
Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method.
International journal of radiation oncology, biology, physics 2001;50(4):937-45.
2001: Fu X L; Huang H; Bentel G; Clough R; Jirtle R L; Kong F M; Marks L B; Anscher M S
Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta.
International journal of radiation oncology, biology, physics 2001;50(4):899-908.
2001: Vujaskovic Z; Anscher M S; Feng Q F; Rabbani Z N; Amin K; Samulski T S; Dewhirst M W; Haroon Z A
Radiation-induced hypoxia may perpetuate late normal tissue injury.
International journal of radiation oncology, biology, physics 2001;50(4):851-5.
2001: Onaitis M W; Noone R B; Hartwig M; Hurwitz H; Morse M; Jowell P; McGrath K; Lee C; Anscher M S; Clary B; Mantyh C; Pappas T N; Ludwig K; Seigler H F; Tyler D S
Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience.
Annals of surgery 2001;233(6):778-85.
2001: Anscher M S
Adjuvant radiotherapy following radical prostatectomy is more effective and less toxic than salvage radiotherapy for a rising prostate specific antigen.
International journal of cancer. Journal international du cancer 2001;96(2):91-3.
2001: Maguire P D; Marks L B; Sibley G S; Herndon J E; Clough R W; Light K L; Hernando M L; Antoine P A; Anscher M S
73.6 Gy and beyond: hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):705-11.
2001: Fan M; Marks L B; Hollis D; Bentel G G; Anscher M S; Sibley G; Coleman R E; Jaszczak R J; Munley M T
Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):543-50.
2001: Kong F M; Anscher M S; Sporn T A; Washington M K; Clough R; Barcellos-Hoff M H; Jirtle R L
Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury.
International journal of radiation oncology, biology, physics 2001;49(1):35-41.
2001: Socinski M A; Marks L B; Garst J; Sibley G S; Blackstock W; Turrisi A; Herndon J; Zhou S; Anscher M; Crawford J; Shafman T; Rosenman J
Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: a preliminary report of a phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
The oncologist 2001;6 Suppl 1():20-4.
2000: Vujaskovic Z; Marks L B; Anscher M S
The physical parameters and molecular events associated with radiation-induced lung toxicity.
Seminars in radiation oncology 2000;10(4):296-307.
2000: Anscher M S; Clough R; Dodge R
Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years.
International journal of radiation oncology, biology, physics 2000;48(2):369-75.
2000: Marks L B; Bentel G; Light K; Zhou S M; Sibley G; Anscher M
Routine 3D treatment planning: opportunities, challenges, and hazards.
Oncology (Williston Park, N.Y.) 2000;14(8):1191-201; discussion 1201, 1205-8.
2000: Zhou S M; Marks L B; Tracton G S; Sibley G S; Light K L; Maguire P D; Anscher M S
A new three-dimensional dose distribution reduction scheme for tubular organs.
Medical physics 2000;27(8):1727-31.
2000: Gebara W J; Weeks K J; Jones E L; Montana G S; Anscher M S
Carcinoma of the uterine cervix: a 3D - CT analysis of dose to the internal, external and common iliac nodes in tandem and ovoid applications.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2000;56(1):43-8.
2000: Anscher M S; Lee C; Hurwitz H; Tyler D; Prosnitz L R; Jowell P; Rosner G; Samulski T; Dewhirst M W
A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer.
International journal of radiation oncology, biology, physics 2000;47(3):719-24.
2000: Marks L B; Fan M; Clough R; Munley M; Bentel G; Coleman R E; Jaszczak R; Hollis D; Anscher M
Radiation-induced pulmonary injury: symptomatic versus subclinical endpoints.
International journal of radiation biology 2000;76(4):469-75.
2000: Wang L W; Fu X L; Clough R; Sibley G; Fan M; Bentel G C; Marks L B; Anscher M S
Can angiotensin-converting enzyme inhibitors protect against symptomatic radiation pneumonitis?
Radiation research 2000;153(4):405-10.
2000: Bentel G C; Munley M T; Marks L B; Anscher M S
The effect of pressure from the table top and patient position on pelvic organ location in patients with prostate cancer.
International journal of radiation oncology, biology, physics 2000;47(1):247-53.
2000: Kong F M; Anscher M S; Washington M K; Killian J K; Jirtle R L
M6P/IGF2R is mutated in squamous cell carcinoma of the lung.
Oncogene 2000;19(12):1572-8.
1999: Anscher M S
More about prostate cancer--expectant management versus treatment.
North Carolina medical journal 1999;60(6):313-4.
1999: Kong F; Jirtle R L; Huang D H; Clough R W; Anscher M S
Plasma transforming growth factor-beta1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma.
Cancer 1999;86(9):1712-9.
1999: Munley M T; Lo J Y; Sibley G S; Bentel G C; Anscher M S; Marks L B
A neural network to predict symptomatic lung injury.
Physics in medicine and biology 1999;44(9):2241-9.
1999: Garipagaoglu M; Munley M T; Hollis D; Poulson J M; Bentel G C; Sibley G; Anscher M S; Fan M; Jaszczak R J; Coleman R E; Marks L B
The effect of patient-specific factors on radiation-induced regional lung injury.
International journal of radiation oncology, biology, physics 1999;45(2):331-8.
1999: Maguire P D; Sibley G S; Zhou S M; Jamieson T A; Light K L; Antoine P A; Herndon J E; Anscher M S; Marks L B
Clinical and dosimetric predictors of radiation-induced esophageal toxicity.
International journal of radiation oncology, biology, physics 1999;45(1):97-103.
1999: Munley M T; Marks L B; Scarfone C; Sibley G S; Patz E F; Turkington T G; Jaszczak R J; Gilland D R; Anscher M S; Coleman R E
Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects.
Lung cancer (Amsterdam, Netherlands) 1999;23(2):105-14.
1999: White R; Lee C; Anscher M; Gottfried M; Wolff R; Keogan M; Pappas T; Hurwitz H; Tyler D
Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.
Annals of surgical oncology 1999;6(1):38-45.
1999: Anscher M S
Prostate cancer in African-American men.
North Carolina medical journal 1999;60(1):10-2.
1999: Hauer-Jensen M; Kong F M; Fink L M; Anscher M S
Circulating thrombomodulin during radiation therapy of lung cancer.
Radiation oncology investigations 1999;7(4):238-42.
1999: Bentel G C; Marks L B; Anscher M S
The effect of beam divergence on target coverage.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 1999;24(2):99-113.
1998: Anscher M S
PSA of 0.5 ng/mL or less and prostate cancer radiation.
Urology 1998;52(3):531.
1998: Zhou S M; Bentel G C; Lee C G; Anscher M S
Differences in gross target volumes on contrast vs. noncontrast CT scans utilized for conformal radiation therapy treatment planning for prostate carcinoma.
International journal of radiation oncology, biology, physics 1998;42(1):73-8.
1998: Anscher M S; Kong F M; Andrews K; Clough R; Marks L B; Bentel G; Jirtle R L
Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis.
International journal of radiation oncology, biology, physics 1998;41(5):1029-35.
1998: Anscher M S; Kong F M; Jirtle R L
The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy.
Lung cancer (Amsterdam, Netherlands) 1998;19(2):109-20.
1998: Sibley G S; Jamieson T A; Marks L B; Anscher M S; Prosnitz L R
Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
International journal of radiation oncology, biology, physics 1998;40(1):149-54.
1998: Gebara W J; Weeks K J; Hahn C A; Montana G S; Anscher M S
Computed axial tomography tandem and ovoids (CATTO) dosimetry: three-dimensional assessment of bladder and rectal doses.
Radiation oncology investigations 1998;6(6):268-75.
1997: DiPaola R S; Weiss R E; Cummings K B; Kong F M; Jirtle R L; Anscher M; Gallo J; Goodin S; Thompson S; Rasheed Z; Aisner J; Todd M B
Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigen.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(11):1999-2004.
1997: Marks L B; Munley M T; Bentel G C; Zhou S M; Hollis D; Scarfone C; Sibley G S; Kong F M; Jirtle R; Jaszczak R; Coleman R E; Tapson V; Anscher M
Physical and biological predictors of changes in whole-lung function following thoracic irradiation.
International journal of radiation oncology, biology, physics 1997;39(3):563-70.
1997: Anscher M S; Samulski T V; Dodge R; Prosnitz L R; Dewhirst M W
Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate.
International journal of radiation oncology, biology, physics 1997;37(5):1059-65.
1997: Anscher M S; Kong F M; Marks L B; Bentel G C; Jirtle R L
Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis.
International journal of radiation oncology, biology, physics 1997;37(2):253-8.
1996: Kong F M; Washington M K; Jirtle R L; Anscher M S
Plasma transforming growth factor-beta 1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker.
Lung cancer (Amsterdam, Netherlands) 1996;16(1):47-59.
1996: Hebert M E; Lowe V J; Hoffman J M; Patz E F; Anscher M S
Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings.
American journal of clinical oncology 1996;19(4):416-21.
1996: Anscher M S
Adjuvant therapy for pathologic stage C prostate cancer: a casualty of the PSA revolution?
International journal of radiation oncology, biology, physics 1996;34(3):745-7.
1995: Anscher M S
Prostate bed massage as a means to determine the source of a rising prostate specific antigen after radical prostatectomy.
American journal of clinical oncology 1995;18(6):481-3.
1995: Das S K; Clegg S T; Anscher M S; Samulski T V
Simulation of electromagnetically induced hyperthermia: a finite element gridding method.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1995;11(6):797-808.
1995: Anscher M S; Robertson C N; Prosnitz R
Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update.
International journal of radiation oncology, biology, physics 1995;33(1):37-43.
1995: Kong F M; Anscher M S; Murase T; Abbott B D; Iglehart J D; Jirtle R L
Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.
Annals of surgery 1995;222(2):155-62.
1995: Chari R S; Tyler D S; Anscher M S; Russell L; Clary B M; Hathorn J; Seigler H F
Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum.
Annals of surgery 1995;221(6):778-86; discussion 786-7.
1995: Wu J J; King S C; Montana G S; McKinstry C A; Anscher M S
The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen.
International journal of radiation oncology, biology, physics 1995;32(2):317-23.
1995: Anscher M S; Kong F M; Murase T; Jirtle R L
Short communication: normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGF beta.
The British journal of radiology 1995;68(807):331-3.
1995: Marks L B; Carroll P R; Dugan T C; Anscher M S
The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy.
International journal of radiation oncology, biology, physics 1995;31(5):1257-80.
1995: Murase T; Anscher M S; Petros W P; Peters W P; Jirtle R L
Changes in plasma transforming growth factor beta in response to high-dose chemotherapy for stage II breast cancer: possible implications for the prevention of hepatic veno-occlusive disease and pulmonary drug toxicity.
Bone marrow transplantation 1995;15(2):173-8.
1995: Bentel G C; Marks L B; Sherouse G W; Spencer D P; Anscher M S
The effectiveness of immobilization during prostate irradiation.
International journal of radiation oncology, biology, physics 1995;31(1):143-8.
1994: Anscher M S; Murase T; Prescott D M; Marks L B; Reisenbichler H; Bentel G C; Spencer D; Sherouse G; Jirtle R L
Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis.
International journal of radiation oncology, biology, physics 1994;30(3):671-6.
1993: Anscher M S; Jones P; Prosnitz L R; Blackstock W; Hebert M; Reddick R; Tucker A; Dodge R; Leight G; Iglehart J D
Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy.
Annals of surgery 1993;218(1):22-8.
1993: Anscher M S; Peters W P; Reisenbichler H; Petros W P; Jirtle R L
Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer.
The New England journal of medicine 1993;328(22):1592-8.
1992: Anscher M S; Marks L B; Shipley W U
The role of radiotherapy in patients with advanced seminomatous germ cell tumors. Controversies in management. Part 2.
Oncology (Williston Park, N.Y.) 1992;6(8):97-104; discussion 107-8, 110.
1992: Marks L B; Anscher M S; Shipley W U
Radiation therapy for testicular seminoma: controversies in the management of early-stage disease.
Oncology (Williston Park, N.Y.) 1992;6(6):43-8; discussion 51-2.
1992: Montana G S; Anscher M S; Mansbach C M; Daly N; Delannes M; Carke-Pearson D; Gaydica E F
Topical application of WR-2721 to prevent radiation-induced proctosigmoiditis. A phase I/II trial.
Cancer 1992;69(11):2826-30.
1992: Anscher M S; Prosnitz L R
Prognostic significance of extent of nodal involvement in stage D1 prostate cancer treated with radiotherapy.
Urology 1992;39(1):39-43.
1992: Kavanagh B; Anscher M; Leopold K; Deutsch M; Gaydica E; Dodge R; Allen K; Allen D; Staub W; Montana G
Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990.
International journal of radiation oncology, biology, physics 1992;24(4):633-42.
1992: Anscher M S; Samulski T V; Leopold K A; Oleson J R
Phase I/II study of external radio frequency phased array hyperthermia and external beam radiotherapy in the treatment of prostate cancer: technique and results of intraprostatic temperature measurements.
International journal of radiation oncology, biology, physics 1992;24(3):489-95.
1992: Marks L B; Anscher M S
Radiotherapy for prostate cancer: should the seminal vesicles be considered target?
International journal of radiation oncology, biology, physics 1992;24(3):435-40.
1991: Marks L B; Anscher M S; Shipley W U
The role of radiation therapy in the treatment of testicular germ cell tumors.
Hematology/oncology clinics of North America 1991;5(6):1143-72.
1991: Anscher M S; Prosnitz L R
Multivariate analysis of factors predicting local relapse after radical prostatectomy--possible indications for postoperative radiotherapy.
International journal of radiation oncology, biology, physics 1991;21(4):941-7.
1991: Anscher M S; Prosnitz L R
Transurethral resection of prostate prior to definitive irradiation for prostate cancer. Lack of correlation with treatment outcome.
Urology 1991;38(3):206-11.
1990: Anscher M S; Prosnitz L R
RE: Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule.
The Journal of urology 1990;143(6):1238-9.
1990: Anscher M S; Crocker I R; Jirtle R L
Transforming growth factor-beta 1 expression in irradiated liver.
Radiation research 1990;122(1):77-85.
1989: Anscher M S; Prosnitz L R
Radiotherapy vs. hormonal therapy for the management of locally recurrent prostate cancer following radical prostatectomy.
International journal of radiation oncology, biology, physics 1989;17(5):953-8.
1989: Anscher M S; Gadd D; Marchetti L; Storch S; Lenahan C R; Gaydica E F; Montana G S
The multidisciplinary approach to adenocarcinoma of the prostate at Moore Regional Hospital.
North Carolina medical journal 1989;50(10):547-55.
1989: Anscher M S; Bentel G C; Murray M J; Oleson J R
Tandem tip fracture: a rare complication of intracavitary therapy of cervix cancer and how to avoid its occurrence.
International journal of radiation oncology, biology, physics 1989;16(2):511-2.
1987: Anscher M S; Prosnitz L R
Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule.
The Journal of urology 1987;138(6):1407-12.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Mitchell S. Anscher

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Mitchell S. Anscher (preview)

All Publications